CareDx, Inc. (CDNA)
64.25
-2.42
(-3.64%)
USD |
NASDAQ |
Oct 16, 12:21
CareDx SG&A Expense (TTM) : 247.69M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 247.69M |
| March 31, 2026 | 225.30M |
| December 31, 2025 | 210.21M |
| September 30, 2025 | 202.68M |
| June 30, 2025 | 198.12M |
| March 31, 2025 | 194.83M |
| December 31, 2024 | 195.82M |
| September 30, 2024 | 190.28M |
| June 30, 2024 | 194.40M |
| March 31, 2024 | 196.68M |
| December 31, 2023 | 201.20M |
| September 30, 2023 | 203.11M |
| June 30, 2023 | 196.76M |
| March 31, 2023 | 197.98M |
| December 31, 2022 | 196.42M |
| September 30, 2022 | 193.55M |
| June 30, 2022 | 187.50M |
| March 31, 2022 | 171.24M |
| December 31, 2021 | 152.21M |
| September 30, 2021 | 136.14M |
| June 30, 2021 | 123.08M |
| March 31, 2021 | 111.61M |
| December 31, 2020 | 102.66M |
| September 30, 2020 | 92.87M |
| June 30, 2020 | 86.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 81.13M |
| December 31, 2019 | 75.43M |
| September 30, 2019 | 67.36M |
| June 30, 2019 | 57.97M |
| March 31, 2019 | 50.27M |
| December 31, 2018 | 43.63M |
| September 30, 2018 | 39.30M |
| June 30, 2018 | 35.44M |
| March 31, 2018 | 31.39M |
| December 31, 2017 | 31.72M |
| September 30, 2017 | 31.52M |
| June 30, 2017 | 32.85M |
| March 31, 2017 | 34.20M |
| December 31, 2016 | 31.89M |
| September 30, 2016 | 30.38M |
| June 30, 2016 | 27.18M |
| March 31, 2016 | 23.28M |
| December 31, 2015 | 20.60M |
| September 30, 2015 | 18.99M |
| June 30, 2015 | 17.30M |
| March 31, 2015 | 16.37M |
| December 31, 2014 | 14.91M |
| September 30, 2014 | 13.67M |
| June 30, 2014 | 12.58M |
| March 31, 2014 | 8.65M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Natera, Inc. | 1.255B |
| Caris Life Sciences, Inc. | 418.96M |
| Myriad Genetics, Inc. | 539.90M |
| BioRestorative Therapies, Inc. | 5.181M |
| Exagen, Inc. | 48.45M |